Asset Allocation

As of March 31, 2026.
Type % Net
Cash 0.01%
Stock 87.41%
Bond 6.51%
Convertible 0.00%
Preferred 0.16%
Other 5.90%
View Asset Allocation
Start Trial

Market Capitalization

As of March 31, 2026
Large 84.49%
Mid 10.28%
Small 5.23%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 91.53%    % Emerging Markets: 1.43%    % Unidentified Markets: 7.05%

Americas 26.00%
25.72%
Canada 2.98%
United States 22.74%
0.28%
Mexico 0.16%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 55.10%
United Kingdom 12.23%
42.23%
France 16.12%
Germany 6.11%
Ireland 2.40%
Italy 4.81%
Netherlands 5.91%
Spain 2.64%
Switzerland 4.21%
0.49%
Turkey 0.49%
0.15%
Israel 0.09%
Nigeria 0.03%
United Arab Emirates 0.03%
Greater Asia 11.85%
Japan 0.00%
1.20%
Australia 1.20%
10.00%
Hong Kong 0.87%
Singapore 1.22%
South Korea 3.07%
Taiwan 4.84%
0.66%
China 0.48%
India 0.14%
Unidentified Region 7.05%

Bond Credit Quality Exposure

AAA --
AA --
A --
BBB --
BB --
B --
Below B --
    CCC --
    CC --
    C --
    DDD --
    DD --
    D --
Not Rated --
Not Available --
Short Term --
No Data Available
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
25.20%
Materials
2.46%
Consumer Discretionary
2.17%
Financials
20.58%
Real Estate
0.00%
Sensitive
49.50%
Communication Services
23.64%
Energy
8.13%
Industrials
4.89%
Information Technology
12.84%
Defensive
19.04%
Consumer Staples
4.25%
Health Care
7.60%
Utilities
7.20%
Not Classified
6.25%
Non Classified Equity
0.09%
Not Classified - Non Equity
6.17%
As of March 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of March 31, 2026
Type % Net
Government 4.06%
Corporate 53.86%
Securitized 33.86%
Municipal 0.00%
Other 8.23%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term --
Less than 1 Year --
Intermediate --
1 to 3 Years --
3 to 5 Years --
5 to 10 Years --
Long Term --
10 to 20 Years --
20 to 30 Years --
Over 30 Years --
Other --
No Data Available
View Bond Maturity Exposure
Start Trial